Jeffrey C Troutt, DO in Helena, OK - Surgery

Jeffrey C Troutt, DO is a Surgery physician based in Helena, Oklahoma. Jeffrey C Troutt is licensed to practice in Oklahoma (license number 2265) and his current practice location is Rr 1 Box 8, Helena, Oklahoma. He can be reached at his office (for appointments etc.) via phone at (580) 852-3221.

NPI number for Jeffrey C Troutt is 1083767214 and his current mailing address is 504 N. Elva, Helena, Oklahoma. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1083767214.

Contact Information

	Jeffrey C Troutt, DO
	Rr 1 Box 8, Helena, OK 73741-9606
	(580) 852-3221
	(580) 852-3208

Physician's Profile

Full Name	Jeffrey C Troutt
Gender	Male
Speciality	Surgery
Location	Rr 1 Box 8, Helena, Oklahoma
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1083767214
Provider Enumeration Date: 01/19/2007
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Jeffrey C Troutt such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1083767214	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208600000X	Surgery	2265 (Oklahoma)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jeffrey C Troutt is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Jeffrey C Troutt, DO 504 N. Elva, Helena, OK 73741 Ph: () -	Jeffrey C Troutt, DO Rr 1 Box 8, Helena, OK 73741-9606 Ph: (580) 852-3221

News Archive

New analysis highlights the global prevalence of HIV among transgender people

A new analysis highlights the prevalence of HIV among transgender individuals worldwide, and shows the need for continued prevention efforts for this population.

Cornerstone announces ANDA filing for generic Tussionex

Cornerstone Therapeutics Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that its product candidate CRTX-067 is an ANDA filing for a generic 10 mg chlorpheniramine polistirex/8 mg hydrocodone polistirex suspension product that will be a generic substitute for the product currently sold under the Tussionex brand name by UCB, Inc.

New study aims to improve understanding of vinyl crib mattress covers

The U.S. continues to look at the use and regulation of phthalates, which have been associated with health problems. Of particular concern is the safety of these plastic additives to children. A new study aims to improve our understanding of one possible exposure route for babies: vinyl crib mattress covers.

Pennsylvania health system decreasing complications, costs with 'warranty' system emphasizing best practices

The Washington Post on Tuesday examined how Pennsylvania's Geisinger Health System has successfully improved outcomes for elective heart surgery patients through its 90-day warranty program, which charges a flat fee covering the cost of the procedure and any needed follow-up care. Geisinger operates its own insurance plan and has 41 clinics, three hospitals and 650 staff physicians.

Oral and intranasal COVID-19 vaccines show promising results in hamster model

A new preprint discusses the protective effect of an oral adenovirus-vectored vaccine based on the SARS-CoV-2 spike against viral transmission and disease in hamsters.

Jeffrey C Troutt, DO - Surgery in Helena, OK